El Guapo Jamaica Hibiscus Flowers in flexible pouches , 1 oz., 2 oz., 8 oz., 16 oz., and 10 lb. box .
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1931-2018.
Mojave Foods Corporation has initiated a recall of its El Guapo Jamaica Hibiscus Flowers in flexible pouches (1 oz., 2 oz., 8 oz., 16 oz., 10 lb.) . UPC # 044989201911, UPC # 044989005229, UPC # 044989012890, UPC # 044989013347,UPC # 079466071985, because of undeclared allergen.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1931-2018.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Mojave Foods Corp. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1931-2018.
Mojave Foods Corp.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Mojave Foods Corp. Recall FAQ
Mojave Foods Corp. is the subject of a food safety report: El Guapo Jamaica Hibiscus Flowers in flexible pouches , 1 oz., 2 oz., 8 oz., 16 oz., and 10 lb. box .. The notice was published on July 27, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 53,081 units are potentially affected.